Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia

Š. Grincevičienė, D. Vaitkienė, D. Kanopienė, R. Vansevičiūtė, J. Tykvart, A. Sukovas, J. Celiešiūtė, E. Ivanauskaitė Didžiokienė, A. Čižauskas, A. Laurinavičienė, V. Král, A. Hlavačková, J. Zemanová, D. Stravinskienė, A. Sližienė, A. Petrošiūtė,...

. 2022 ; 12 (1) : 15397. [pub] 20220913

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024426

Grantová podpora
P-SEN-20-28 Lietuvos Mokslo Taryba
P-SEN-20-28 Lietuvos Mokslo Taryba
P-SEN-20-28 Lietuvos Mokslo Taryba
17-14510S Grantová Agentura České Republiky
RVO:61388963 Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences

Precancerous lesions of human cervix uteri have a tendency for regression or progression. In cervical intraepithelial neoplasia grade 2 (CINII) case there is an uncertainty if a lesion will progress or regress. The carbonic anhydrase IX (CAIX) enzyme is overexpressed in cervical cancer which is more sensitive to radiotherapy. CAIX is associated with poor prognosis in solid hypoxic tumors. The aim of this study was to determine factors related to elevated soluble CAIX (s-CAIX) in high-grade intraepithelial lesion (HSIL) cases.METHODS: Patients diagnosed with HSIL (N = 77) were included into the research group whereas without HSIL (N = 72)-the control group. Concentration of the soluble CAIX (s-CAIX) in plasma was determined by the DIANA ligand-antibody-based method. C. trachomatis was detected from cervical samples by PCR. Primary outcomes were risk factors elevating s-CAIX level in HSIL group. Non-parametric statistical analysis methods were used to calculate correlations. RESULTS: The s-CAIX level in patients with HSIL was elevated among older participants (rs = 0.27, p = 0.04) and with C. trachomatis infection (p = 0.028). Among heavy smokers with HSIL, the concentration of s-CAIX was higher in older women (rs = 0.52, p = 0.005), but was not related to the age of heavy smokers' controls (τ = 0.18 p = 0.40). CONCLUSION: The concentration of s-CAIX was higher among older, heavy smoking and diagnosed with C. trachomatis patients. All these factors increased the risk for HSIL progression.

Clinic of Obstetrics and Gynecology Faculty of Medicine Institute of Clinical Medicine Vilnius University M K Ciurlionio st 21 03101 Vilnius Lithuania

Consultative Polyclinic Department National Cancer Institute Santariskiu st 1 08406 Vilnius Lithuania

Department of Biothermodynamics and Drug Design Institute of Biotechnology Life Sciences Center Vilnius University Sauletekio sl 7 10257 Vilnius Lithuania

Department of Immunology and Cell Biology Institute of Biotechnology Life Sciences Center Vilnius University Sauletekio sl 7 10257 Vilnius Lithuania

Department of Obstetrics and Gynecology Medical Academy Lithuanian University of Health Sciences Eiveniu st 2 50161 Kaunas Lithuania

Department of Pathological Anatomy Medical Academy Lithuanian University of Health Sciences Eiveniu st 2 50161 Kaunas Lithuania

Department of Pathology Forensic Medicine and Pharmacology Institute of Biomedical Science Faculty of Medicine Vilnius University M K Ciurlionio st 21 03101 Vilnius Lithuania

Diana Biotechnologies Nad Safinou 2 366 252 50 Vestec Czech Republic

Institute of Molecular Genetics of the Czech Academy of Sciences Flemingovo n 2 166 37 Prague 6 Czech Republic

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo náměstí 542 2 160 00 Praha Czech Republic

National Center of Pathology Affiliate of Vilnius University Hospital Santaros Klinikos P Baublio st 5 08406 Vilnius Lithuania

Pharmacy Center Institute of Biomedical Science Faculty of Medicine Vilnius University M K Ciurlionio st 21 03101 Vilnius Lithuania

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024426
003      
CZ-PrNML
005      
20221031100250.0
007      
ta
008      
221017s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-022-19492-y $2 doi
035    __
$a (PubMed)36100684
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Grincevičienė, Švitrigailė $u Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio sl. 7, 10257, Vilnius, Lithuania. svitrigaile.grinceviciene@bti.vu.lt
245    10
$a Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia / $c Š. Grincevičienė, D. Vaitkienė, D. Kanopienė, R. Vansevičiūtė, J. Tykvart, A. Sukovas, J. Celiešiūtė, E. Ivanauskaitė Didžiokienė, A. Čižauskas, A. Laurinavičienė, V. Král, A. Hlavačková, J. Zemanová, D. Stravinskienė, A. Sližienė, A. Petrošiūtė, V. Petrauskas, R. Balsytė, J. Grincevičius, V. Navratil, U. Jahn, J. Konvalinka, A. Žvirblienė, D. Matulis, J. Matulienė
520    9_
$a Precancerous lesions of human cervix uteri have a tendency for regression or progression. In cervical intraepithelial neoplasia grade 2 (CINII) case there is an uncertainty if a lesion will progress or regress. The carbonic anhydrase IX (CAIX) enzyme is overexpressed in cervical cancer which is more sensitive to radiotherapy. CAIX is associated with poor prognosis in solid hypoxic tumors. The aim of this study was to determine factors related to elevated soluble CAIX (s-CAIX) in high-grade intraepithelial lesion (HSIL) cases.METHODS: Patients diagnosed with HSIL (N = 77) were included into the research group whereas without HSIL (N = 72)-the control group. Concentration of the soluble CAIX (s-CAIX) in plasma was determined by the DIANA ligand-antibody-based method. C. trachomatis was detected from cervical samples by PCR. Primary outcomes were risk factors elevating s-CAIX level in HSIL group. Non-parametric statistical analysis methods were used to calculate correlations. RESULTS: The s-CAIX level in patients with HSIL was elevated among older participants (rs = 0.27, p = 0.04) and with C. trachomatis infection (p = 0.028). Among heavy smokers with HSIL, the concentration of s-CAIX was higher in older women (rs = 0.52, p = 0.005), but was not related to the age of heavy smokers' controls (τ = 0.18 p = 0.40). CONCLUSION: The concentration of s-CAIX was higher among older, heavy smoking and diagnosed with C. trachomatis patients. All these factors increased the risk for HSIL progression.
650    _2
$a senioři $7 D000368
650    _2
$a antigeny nádorové $x metabolismus $7 D000951
650    _2
$a karboanhydrasa IX $x metabolismus $7 D000071231
650    12
$a karboanhydrasy $7 D002256
650    12
$a dysplazie děložního hrdla $7 D002578
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a nádory děložního čípku $7 D002583
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vaitkienė, Daiva $u Department of Obstetrics and Gynecology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu st. 2, 50161, Kaunas, Lithuania
700    1_
$a Kanopienė, Daiva $u Consultative Polyclinic Department, National Cancer Institute, Santariskiu st. 1, 08406, Vilnius, Lithuania
700    1_
$a Vansevičiūtė, Rasa $u Consultative Polyclinic Department, National Cancer Institute, Santariskiu st. 1, 08406, Vilnius, Lithuania $u Clinic of Obstetrics and Gynecology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, M. K. Ciurlionio st. 21, 03101, Vilnius, Lithuania
700    1_
$a Tykvart, Jan $u Diana Biotechnologies, Nad Safinou II 366, 252 50, Vestec, Czech Republic
700    1_
$a Sukovas, Artūras $u Department of Obstetrics and Gynecology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu st. 2, 50161, Kaunas, Lithuania
700    1_
$a Celiešiūtė, Joana $u Department of Obstetrics and Gynecology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu st. 2, 50161, Kaunas, Lithuania
700    1_
$a Ivanauskaitė Didžiokienė, Ernesta $u National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos, P. Baublio st. 5, 08406, Vilnius, Lithuania
700    1_
$a Čižauskas, Arvydas $u Department of Pathological Anatomy, Medical Academy, Lithuanian University of Health Sciences, Eiveniu st. 2, 50161, Kaunas, Lithuania
700    1_
$a Laurinavičienė, Aida $u National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos, P. Baublio st. 5, 08406, Vilnius, Lithuania $u Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, M. K. Ciurlionio st. 21, 03101, Vilnius, Lithuania
700    1_
$a Král, Vlastimil $u Institute of Molecular Genetics of the Czech Academy of Sciences, Flemingovo n. 2, 166 37, Prague 6, Czech Republic
700    1_
$a Hlavačková, Anna $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, 160 00, Praha, Czech Republic
700    1_
$a Zemanová, Jitka $u Diana Biotechnologies, Nad Safinou II 366, 252 50, Vestec, Czech Republic
700    1_
$a Stravinskienė, Dovilė $u Department of Immunology and Cell Biology, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio sl. 7, 10257, Vilnius, Lithuania
700    1_
$a Sližienė, Aistė $u Department of Immunology and Cell Biology, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio sl. 7, 10257, Vilnius, Lithuania
700    1_
$a Petrošiūtė, Agnė $u Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio sl. 7, 10257, Vilnius, Lithuania
700    1_
$a Petrauskas, Vytautas $u Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio sl. 7, 10257, Vilnius, Lithuania
700    1_
$a Balsytė, Renata $u Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio sl. 7, 10257, Vilnius, Lithuania
700    1_
$a Grincevičius, Jonas $u Pharmacy Center, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, M. K. Ciurlionio st. 21, 03101, Vilnius, Lithuania
700    1_
$a Navratil, Vaclav $u Diana Biotechnologies, Nad Safinou II 366, 252 50, Vestec, Czech Republic
700    1_
$a Jahn, Ullrich $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, 160 00, Praha, Czech Republic
700    1_
$a Konvalinka, Jan $u Diana Biotechnologies, Nad Safinou II 366, 252 50, Vestec, Czech Republic $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, 160 00, Praha, Czech Republic
700    1_
$a Žvirblienė, Aurelija $u Department of Immunology and Cell Biology, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio sl. 7, 10257, Vilnius, Lithuania
700    1_
$a Matulis, Daumantas $u Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio sl. 7, 10257, Vilnius, Lithuania
700    1_
$a Matulienė, Jurgita $u Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio sl. 7, 10257, Vilnius, Lithuania
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 12, č. 1 (2022), s. 15397
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36100684 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100247 $b ABA008
999    __
$a ok $b bmc $g 1854249 $s 1175716
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 12 $c 1 $d 15397 $e 20220913 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
GRA    __
$a P-SEN-20-28 $p Lietuvos Mokslo Taryba
GRA    __
$a P-SEN-20-28 $p Lietuvos Mokslo Taryba
GRA    __
$a P-SEN-20-28 $p Lietuvos Mokslo Taryba
GRA    __
$a 17-14510S $p Grantová Agentura České Republiky
GRA    __
$a RVO:61388963 $p Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Možnosti archivace